The FDA has announced a Class II recall of certain 40mg pantoprazole sodium tablets after reports of unusual discoloration. The affected batch, produced by Hetero Labs and sold by Camber ...

One batch of pantoprazole, a common heartburn or acid reflux medication, has been recalled due to tablet discoloration.

The FDA has announced a nationwide Class II recall of over 4,000 bottles of pantoprazole sodium tablets after reports of ...

LOS ANGELES, July 31 (Reuters) - Wyeth and its partner Nycomed said on Tuesday that Teva Pharmaceuticals and Sun Pharmaceuticals have committed to not launching generic versions of heartburn drug ...

THE DEAL: Two generic drugmakers will pay $2.15 billion to Pfizer Inc. and Takeda Pharmaceuticals to resolve a lawsuit over the heartburn drug Protonix. THE LAUNCH: Teva Pharmaceutical Industries Ltd.

Legislators also push RFK Jr. on drug pricing deals, efforts to remake preventive services ...

NEW YORK, June 25 (Reuters) - Wyeth said on Monday it asked a New Jersey federal court to stop Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. from launching generic forms ...

Teva Pharmaceutical Industries Ltd. may be on the hook for up to $2.1 billion in damages because it sold generic copies of Pfizer Inc.'s heartburn reliever Protonix before the drug's U.S. patent ...

Teva has already been awarded a 180-day period of market exclusivity for being the first company to file for a generic version of the drug, which the Food and Drug Administration approved in August.

NEW YORK (AP) — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., ...